Fosun Pharma Looks To Expand To Western Markets

Fosun Pharma, which is based in China, is looking to expand to the west. The company’s chairman, Chen Qiyu, says that although China and India will remain the main production bases for the firm, it has eyes on the US and European markets for its generic drugs. Chen called the US the most important market for the company after China. Fosun has made major acquisitions in recent years, and recently acquired a significant stake in India based Gland Pharma. Gland Pharma is a major presence in the generic injectables market.

Read the source article at South China Morning Post